As no specific laboratory test is available for the identification of AAE-ACEI, this disorder can be diagnosed only by excluding other types of bradykinin-mediated angioedema (32, 33), when the complement tests are performed at the discontinuation of ACE inhibitors (Table 1) (32, 34). This evidence concerns the gene ACE and angioedema.